722PExploratory analyses of 400 patients enrolled in 2 FFCD trials of first line treatment for metastatic pancreatic cancer. (23rd October 2018) - Taieb, J; Phelip, J M; Rinaldi, Y; Barbier, E; Bouche, O; Khemissa Akouz, F; Gratet, A; Petorin, C; Miglianico, L; Malka, D; Laharie Mineur, H; Rebischung, C; et al.